Tryptamine Therapeutics 주식 가격. TYP - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

0.04

매수가

0.04

매도가

0.041

거래량

3,907,876

0.04 일간 변동폭 0.041

0.017 52주 범위 0.057

market_cap

45.557M

전일 종가

0.04

개장가

0.04

최근 거래 시간

3000

0.041

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

1,663,996

발행 주식

1,138,922,000

배당수익률

주가수익률

-7.41

주당순이익(EPS)

-0.01

매출

1.11M

순이익

-6.14M

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

tryptherapeutics.com/

본부

Melbourne, Victoria, Aus

설립됨

Tryptamine Therapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the 호주 증권거래소 with ticker TYP. The last closing price for Tryptamine Therapeutics was AUD0.04. Over the last year, Tryptamine Therapeutics shares have traded in a share price range of AUD 0.017 to AUD 0.057.

Tryptamine Therapeutics currently has 1,138,922,000 shares in issue. The market capitalisation of Tryptamine Therapeutics is AUD45.56 million. Tryptamine Therapeutics has a price to earnings ratio (PE ratio) of -7.41.

No news to show yet.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.002	5.26315789474	0.038	0.041	0.034	939228	0.03578639	DE
4	0.003	8.10810810811	0.037	0.041	0.031	1313931	0.03529134	DE
12	-0.008	-16.6666666667	0.048	0.05	0.031	1663996	0.03935591	DE
26	0.02	100	0.02	0.057	0.017	2543620	0.03509667	DE
52	0.014	53.8461538462	0.026	0.057	0.017	2575507	0.03129148	DE
156	0.014	53.8461538462	0.026	0.057	0.017	2575507	0.03129148	DE
260	0.014	53.8461538462	0.026	0.057	0.017	2575507	0.03129148	DE

TYP - Frequently Asked Questions (FAQ)

What is the current Tryptamine Therapeutics share price?

The current share price of Tryptamine Therapeutics is AUD 0.04

How many Tryptamine Therapeutics shares are in issue?

Tryptamine Therapeutics has 1,138,922,000 shares in issue

What is the market cap of Tryptamine Therapeutics?

The market capitalisation of Tryptamine Therapeutics is AUD 45.56M

What is the 1 year trading range for Tryptamine Therapeutics share price?

Tryptamine Therapeutics has traded in the range of AUD 0.017 to AUD 0.057 during the past year

What is the PE ratio of Tryptamine Therapeutics?

The price to earnings ratio of Tryptamine Therapeutics is -7.41

What is the cash to sales ratio of Tryptamine Therapeutics?

The cash to sales ratio of Tryptamine Therapeutics is 40

What is the reporting currency for Tryptamine Therapeutics?

Tryptamine Therapeutics reports financial results in AUD

What is the latest annual turnover for Tryptamine Therapeutics?

The latest annual turnover of Tryptamine Therapeutics is AUD 1.11M

What is the latest annual profit for Tryptamine Therapeutics?

The latest annual profit of Tryptamine Therapeutics is AUD -6.14M

What is the registered address of Tryptamine Therapeutics?

The registered address for Tryptamine Therapeutics is SUITE 201, 697 BURKE ROAD, CAMBERWELL, MELBOURNE, VICTORIA

What is the Tryptamine Therapeutics website address?

The website address for Tryptamine Therapeutics is tryptherapeutics.com/

Which industry sector does Tryptamine Therapeutics operate in?

Tryptamine Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
FXGOFelix Gold Ltd	AUD 0.06 (185.71%)	500k
AVEOAAvecho Biotechnology Limited	AUD 0.002 (100.00%)	172.2M
SCNScorpion Minerals Limited	AUD 0.026 (73.33%)	5.32M
BP8BPH Global Ltd	AUD 0.005 (66.67%)	10.48M
M2RMiramar Resources Limited	AUD 0.005 (66.67%)	7.82M
BPMOBBPM Minerals Limited	AUD 0.005 (-37.50%)	935.9k
CR9Corella Resources Limited	AUD 0.002 (-33.33%)	160.46k
PR2OPiche Resources Ltd	AUD 0.015 (-31.82%)	150k
SKKStakk Ltd	AUD 0.005 (-28.57%)	2.33M
PFTPure Foods Tasmania Limited	AUD 0.015 (-28.57%)	13.01k
AVEOAAvecho Biotechnology Limited	AUD 0.002 (100.00%)	172.2M
SIGSigma Healthcare Limited	AUD 3.105 (7.44%)	82.16M
PNRPantoro Limited	AUD 0.15 (5.26%)	67.21M
IMUImugene Limited	AUD 0.043 (10.26%)	66.28M
AVEAvecho Biotechnology Limited	AUD 0.0065 (30.00%)	61.24M